TRAF7

Chr 16AD

TNF receptor associated factor 7

Also known as: CAFDADD, RFWD1, RNF119

Tumor necrosis factor (TNF; see MIM 191160) receptor-associated factors, such as TRAF7, are signal transducers for members of the TNF receptor superfamily (see MIM 191190). TRAFs are composed of an N-terminal cysteine/histidine-rich region containing zinc RING and/or zinc finger motifs; a coiled-coil (leucine zipper) motif; and a homologous region that defines the TRAF family, the TRAF domain, which is involved in self-association and receptor binding.[supplied by OMIM, Apr 2004]

OMIMResearchGenerating clinical summary…
MultiplemechanismADLOEUF 0.461 OMIM phenotype
Clinical SummaryTRAF7
🧬
Gene-Disease Validity (ClinGen)
syndromic complex neurodevelopmental disorder · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.28) despite low pLI — interpret in context.
📋
ClinVar Variants
21 unique Pathogenic / Likely Pathogenic· 133 VUS of 256 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Missense constrained — critical functional residues
LoF Constraint?
0.46LOEUF
pLI 0.022
Z-score 4.24
OE 0.28 (0.170.46)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
3.26Z-score
OE missense 0.56 (0.510.63)
248 obs / 440.6 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.28 (0.170.46)
00.351.4
Missense OE?0.56 (0.510.63)
00.61.4
Synonymous OE?1.14
01.21.6
LoF obs/exp: 11 / 39.9Missense obs/exp: 248 / 440.6Syn Z: -1.53
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongTRAF7-related developmental delay congenital anomalies and dysmorphic featuresOTHERAD

This gene — mechanism propensity

DN
0.6840th %ile
GOF
0.6443th %ile
LOF
0.4136th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). The Badonyi & Marsh model scores dominant-negative highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports gain-of-function. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median · 1 literature citation · 95% of P/LP are missense
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

GOFThe second group included eight (31%) BAP1-wild-type tumors: two with TP53 mutations, one with a TRAF7 activating mutation, one with a SUZ12 inactivating mutation, and three with ALK rearrangements that we previously published.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 32504035

ClinVar Variant Classifications

256 submitted variants in ClinVar

Classification Summary

Pathogenic7
Likely Pathogenic14
VUS133
Likely Benign53
Benign10
Conflicting6
7
Pathogenic
14
Likely Pathogenic
133
VUS
53
Likely Benign
10
Benign
6
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
7
0
0
7
Likely Pathogenic
0
13
1
0
14
VUS
14
115
4
0
133
Likely Benign
0
16
7
30
53
Benign
0
1
4
5
10
Conflicting
6
Total141521635223

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

36 pathogenic / likely-pathogenic (of 53) ClinVar copy-number / structural variants overlap TRAF7 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

TRAF7 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →